Metraipolis › archive › dc_81da7a2bb700
NRN1 as a therapeutic target for Alzheimer's disease — Europe PMC PMID:41645874
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41645874
- DOI
- 10.1002/alz.71149
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T09:23:38.761Z
- SHA-256 of the archived text
a5fe6c7f15d136893cafd8dddef4b22df4e9615212c9a1fca48053435bcce3d7- Stable URL of this page
https://metraipolis.com/documento/dc_81da7a2bb700
How to cite
NRN1 as a therapeutic target for Alzheimer's disease — Europe PMC PMID:41645874 — Europe PMC (en), https://europepmc.org/article/MED/41645874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_81da7a2bb700 (Metraipolis archive dc_81da7a2bb700, sha256 a5fe6c7f15d136893cafd8dddef4b22df4e9615212c9a1fca48053435bcce3d7)
BibTeX
@misc{dc81da7a2bb700,
title = {NRN1 as a therapeutic target for Alzheimer's disease — Europe PMC PMID:41645874},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41645874},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_81da7a2bb700; sha256 a5fe6c7f15d136893cafd8dddef4b22df4e9615212c9a1fca48053435bcce3d7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41645874. Agents can read the archived copy with the MCP tool read_document.